HN

Hemanshu Nitinchandra Pandya

Active Director Director DIN 10383995
DIN 10383995 First appointment Nov 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value •••• Premium profile

About Hemanshu Nitinchandra Pandya

Data last updated:

Hemanshu Nitinchandra Pandya is a Director at Senores Pharmaceuticals Limited (since 2023). The company operates in Pharma. Senores Pharmaceuticals Limited reported revenue of ₹418 Cr (FY 2025).

DIN 10383995
Primary Designation Director
Industry Pharma
First Appointment 10 Nov 2023
Oldest Company Age 8 yrs
Largest company Senores Pharmaceuticals Limited · ₹418 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Senores Pharmaceuticals Limited L24290GJ2017PLC100263
Director10 Nov 20232017₹418 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Senores Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Hemanshu Nitinchandra Pandya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hemanshu Nitinchandra Pandya

Hemanshu Nitinchandra Pandya currently holds 1 directorship: Senores Pharmaceuticals Limited (Director, since 10 Nov 2023, revenue ₹418 Cr (FY 2025)).

Hemanshu Nitinchandra Pandya was first appointed on 10 Nov 2023 as Director at Senores Pharmaceuticals Limited.

The current boards of Hemanshu Nitinchandra Pandya's companies include Arpit Deepakkumar Shah (Senores Pharmaceuticals Limited), Ashokkumar Vijaysinh Barot (Senores Pharmaceuticals Limited), Chetan Bipinchandra Shah (Senores Pharmaceuticals Limited), Deval Rajnikant Shah (Senores Pharmaceuticals Limited), Deval Rajnikant Shah (Senores Pharmaceuticals Limited), Jitendra Babulal Sanghvi (Senores Pharmaceuticals Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available